Gadegbeku, Crystal

FGF23 induces left ventricular hypertrophy

Faul, C., Amaral, A. P., Oskouei, B., Hu, M.-C., Sloan, A., Isakova, T., Gutiérrez, O. M., Aguillon-Prada, R., Lincoln, J., Hare, J. M., et al. (2011) · Journal of Clinical Investigation

Parathyroid Disorders and TreatmentsCardiac Fibrosis and Remodeling

Cited by 2,027

A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease

Delgado, C., Baweja, M., Crews, D. C., Eneanya, N. D., Gadegbeku, C. A., Inker, L. A., Mendu, M. L., Miller, W. G., Moxey-Mims, M. M., Roberts, G. V., et al. (2022) · American Journal of Kidney Diseases

Chronic Kidney Disease and DiabetesClinical Laboratory Practices and Quality Control

Cited by 783

Chronic Renal Insufficiency Cohort (CRIC) Study: Baseline Characteristics and Associations with Kidney Function

Lash, J. P., Go, A. S., Appel, L. J., He, J., Ojo, A., Rahman, M., Townsend, R. R., Xie, D., Cifelli, D., Cohan, J., et al. (2009) · Clinical Journal of the American Society of Nephrology

Chronic Kidney Disease and DiabetesDialysis and Renal Disease Management

Cited by 619

Myeloperoxidase Levels and Its Product 3-Chlorotyrosine Predict Chronic Kidney Disease Severity and Associated Coronary Artery Disease

Afshinnia, F., Zeng, L., Byun, J., Gadegbeku, C. A., Magnone, M. C., Whatling, C., Valastro, B., Kretzler, M., Pennathur, S., & Michigan Kidney Translational Core CPROBE Investigator Group (2017) · American Journal of Nephrology

Neutrophil, Myeloperoxidase and Oxidative MechanismsChronic Kidney Disease and Diabetes

Cited by 43

Individualised treatment effects of corticosteroids in IgA nephropathy

Hölscher, D. L., Schmitz, N. E. J., Niggemeier, L., Pilva, P., Strauch, M., Tesar, V., Barratt, J., Roberts, I. S. D., Coppo, R., Barisoni, L., et al. (2026) · eBioMedicine

Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes

Cited by 2